Human equivalent age based on size and other factors.
Karyogram (Chromosome painting)
These clinical genetic traits can inform clinical decisions and diagnoses. These traits do not predict a disease state or increased risk for disease. We currently assess one clinical trait: Alanine Aminotransferase Activity.
Alanine Aminotransferase Activity result: Low Normal
Maggie has two copies of a mutation associated with reduced ALT activity. Please inform your veterinarian that Maggie has this genotype, as ALT is often used as an indicator of liver health and Maggie is likely to have a lower than average resting ALT activity. As such, an increase in Maggie’s ALT activity could be evidence of liver damage, even if it is within normal limits by standard ALT reference ranges.
More information on Alanine Aminotransferase Activity:
Known to be highly expressed in liver cells, activity levels of alanine aminotransferase, or ALT, is a common value on most blood chemistry panels and is known to be a sensitive measure of liver health. Dogs with two ancestral G alleles show "normal" activity. Dogs that have one or two copies of the derived A allele may have lower resting levels of ALT activity, known as "low normal". If your dog's result is "low normal" then when a blood chemistry panel is being interpreted the values that you and your veterinarian consider "normal" may need to be adjusted. Please note that neither a "normal" nor a "low normal" result for this predicts a disease state or increased risk for liver disease. Moreover, this mutation does not associate with increased levels of ALT: If your dog has high ALT levels, please consult your veterinarian.
How to interpret these results:
AT RISK status: Testing positive (AT RISK) is predictive of your dog being affected by this condition, but it is not a final diagnosis nor does it predict when symptoms may occur or the severity of a condition in your dog.
CARRIER status: This indicates the dog has inherited a recessive allele for a genetic trait or mutation. This is not enough to cause symptoms of the disease, but
is important to bear in mind if the dog ever has offspring.
Not AT RISK for any conditions tested.
Not a CARRIER for any conditions tested.
All other health conditions tested
Maggie tested CLEAR for all these conditions:
Multidrug Sensitivity (MDR1) (Chromosome 14)
P2RY12 Defect (P2RY12) (Chromosome 23)
Factor IX Deficiency, Hemophilia B (F9 Exon 7, Terrier Variant) (Chromosome X)
Factor IX Deficiency, Hemophilia B (F9 Exon 7, Rhodesian Ridgeback Variant) (Chromosome X)
Factor VII Deficiency (F7 Exon 5) (Chromosome 22)
Factor VIII Deficiency, Hemophilia A (F8 Exon 10, Boxer Variant) (Chromosome X)
Factor VIII Deficiency, Hemophilia A (F8 Exon 11, Shepherd Variant 1) (Chromosome X)
Factor VIII Deficiency, Hemophilia A (F8 Exon 1, Shepherd Variant 2) (Chromosome X)
Embark Veterinary is a canine consumer genetics company offering research-grade genetic tests to owners and breeders.
Embark is a research partner of the Cornell University College of Veterinary Medicine and collaborates with scientists and registries to accelerate genetic research in canine health.
The Embark test is the only comprehensive test on the market, providing results for over 160 genetic health conditions and accurate breed identification based on over 200,000 genetic markers.
We strive to make it easy for customers and vets to understand, share and use their dog’s unique genetic profile to improve their pet’s health and happiness.
You can learn more on our website embarkvet.com
For enquiries please contact us at email@example.com